Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An exonic splicing enhancer (ESE) motif is a short, cis-acting DNA/RNA sequence element (typically 6 bases long) located within exons that enhances the accuracy of pre-mRNA splicing. ESEs function as binding sites for SR proteins, which are splicing factors that help recognize splice sites, recruit spliceosomal components, and regulate exon definition and alternative splicing. ESE motifs are not considered therapeutic targets in the traditional sense because they are intrinsic DNA sequences, not proteins or discrete molecular entities that can be directly bound or inhibited by drugs. While mutations in ESEs can lead to disease-causing splicing defects, the motifs themselves serve as biomarkers rather than direct therapeutic targets. The actual therapeutic opportunities in this pathway lie in modulating the SR proteins that bind to ESEs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exonic splicing enhancer motif (ESE).